Practical guidelines for clinicians who treat patients with amiodarone

Archives of Internal Medicine

Volumn 160, Issue 12, 2000, Pages 1741-1748

  Goldschlager, Nora ^a   Epstein, Andrew E ^a   Naccarelli, Gerald ^a   Olshansky, Brian ^a   Singh, Braman ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ANOREXIA; ARTICLE; ATAXIA; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONSTIPATION; COUGHING; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTHYROIDISM; IMPOTENCE; NAUSEA; OPTIC NERVE DISEASE; PHOTOSENSITIVITY DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT INTERVAL; SLEEP DISORDER; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 0034717559     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.12.1741     Document Type: Article

References (29)

1. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT (European Myocardial Infarct Amiodarone Trial Investigators) [published correction appears in Lancet. 1997;349:1180, 1776]. Lancet. 1997;349:667-674.
2. Julian DG, Camm AJ, Frangin G, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT (European Myocardial Infarct Amiodarone Trial Investigators) [published correction appears in Lancet. 1997;349:1180, 1776]. Lancet. 1997;349:667-674.
3. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT [published correction appears in Lancet. 1997;349:1776]. Lancet. 1997;349:675-682.
4. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT [published correction appears in Lancet. 1997;349:1776]. Lancet. 1997;349:675-682.
5. Doval HC, Nul DR, Grancelli HO, et al, for Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493-498.
6. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure (CHF-STAT). N Engl J Med. 1995;333:77-82.
7. The CASCADE Investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol. 1993; 72:280-287.
8. The AntiarrhythmicsVersus Implantable Defibrillators(AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337: 1576-1583.
9. Siebels J, Cappato R, Ruppel R, et al, for the CASH Investigators. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol. 1993;72:109F-113F.
10. Connolly SJ, Gent M, Roberts RS, et al, for the CIDS Co-Investigators. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol. 1993;72:103F-108F.
11. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997; 337:1785-1791.
12. Scheinman MM, Levine JH, Cannom DS, et al, for the Intravenous Amiodarone Multicenter Investigators Group. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 1995;92: 3264-3272.
13. Kowey PR, Levine JH, Herre JM, et al, for the Intravenous Amiodarone Multicenter Investigators Group. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 1995;92:3255-3263.
14. Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol. 1996;27:1079-1082.
15. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry DR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol. 1999;34:343-347.
16. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res. 1997;35:13-29.
17. Singh BN. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. Am J Cardiol. 1996;78(suppl 4A):41-53.
18. Kalbfleisch SJ, Williamson B, Man KC, et al. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia. J Am Coll Cardiol. 1993;22:1723-1729.
19. Evans SJL, Myers M, Zaher C, et al. High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance. J Am Coll Cardiol. 1992;19:169-173.
20. Singh BN. Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol. 1997;20:608-618.
21. Desai AD, Chun S, Sung RJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med. 1997;127:294-303.
22. Raeder EA, Podrid PJ, Lown B. Side effects and complications of amiodarone therapy. Am Heart J. 1985;109:975-983.
23. Mason JW. Amiodarone. N Engl J Med. 1987; 316:455-466.
24. Jafari-Fesharaki M, Scheinman MM. Adverse effects of amiodarone. Pacing Clin Electrophysiol. 1998;21:108-120.
25. Singh SN, Fisher SG, Deedwania PC, et al, for the Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators. Pulmonary effect of amiodarone in patients with heart failure. J Am Coll Cardiol. 1997;30:514-517.
26. Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30:791-798.
27. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med. 1997;126:63-73.
28. Marcus FI. Drug interactions with amiodarone. Am Heart J. 1983;106:924-930.
29. Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med. 1984;311:167-172.